ScreenerHero
NAVANavamedic ASA
OSL · NO · Healthcare · Medical Distribution · navamedic.com
15.55NOK+0.65%Mkt Cap: 34.86M $P/E: —

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includ…

Industry Peers

Medical Distribution
Screen all
MCK
McKesson Corporation
$99.53BUSDP/E 22.9
COR
CoreSite Realty Corporation
$60.51BUSDP/E 23.5
CAH
Cardinal Health, Inc.
$54.62BUSDP/E 32.4
HSIC
Henry Schein, Inc.
$10.17BUSDP/E 26.0
GALE
Galenica AG
$4.70BUSDP/E 25.6
SELEC
Selcuk Ecza Deposu Ticaret ve Sanayi A.S.
$4.22BUSDP/E 79.3
AMP
Amplifon S.p.A.
$3.42BUSDP/E 38.2
ASKER
Asker Healthcare Group AB
$2.81BUSDP/E 43.1
UPR
Uniphar plc
$1.17BUSDP/E 20.7
ARJO-B
Arjo AB (publ)
$747.71MUSDP/E 20.2
M12
M1 Kliniken AG
$371.48MUSDP/E 15.3
ILM1
Medios AG
$301.63MUSDP/E 23.7
BLC
Bastide Le Confort Medical SA
$180.35MUSDP/E 18.0
MLFMV
Farminveste, S.G.P.S., S.A.
$115.23MUSD
ACH
Aluminum Corporation of China Limited
$101.51MUSD
RMAH
Farmaceutica REMEDIA S.A.
$18.14MUSDP/E 11.1
ALEMG
Euromedis Groupe
$15.46MUSD
WGRX
Wellgistics Health Inc. Common Stock
$8.85MUSD
MEDS
Trxade Group, Inc.
$4.38MUSD
MLMIB
Metrics in Balance N.V.
$157.5KUSD

Key Statistics

Company
Market Cap34.86M $
Enterprise Value46.81M $
Revenue (TTM)53.69M $
Gross Profit20.60M $
Net Income (TTM)-2.20M $
Revenue/Share2.402 USD
Last Price15.55 NOK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees38
CountryNO
SectorHealthcare
IndustryMedical Distribution
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)50.40
PEG1.38
EV/EBITDA10.61
EV/Revenue0.87
P/S0.66
P/B1.18
EPS (TTM)-1.08
EPS (Forward)0.31
52W Range
15.104% of range26.50
52W High26.50 NOK
52W Low15.10 NOK
Profitability
Gross Margin38.97%
Oper. Margin1.10%
EBITDA Margin8.22%
Profit Margin-4.16%
ROE-7.05%
ROA-3.17%
Growth
Revenue Growth2.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.39M $
CapEx (TTM)222.57K $
FCF Margin5.51%
FCF Yield8.48%
Net Debt12.16M $
Net Debt/EBITDA2.76
Balance Sheet
Debt/Equity0.68
Current Ratio1.47
Quick Ratio0.74
Book Value/Sh13.37 NOK
Cash/Share2.207 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 13, 2010
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.00 NOK
Upside (mean)+35.0%
Target Range21.00 NOK – 21.00 NOK
# Analysts2
Ownership
Shares Out.23.98M
Float10.94M
Insiders69.18%
Institutions18.07%
Technical
SMA 5016.51 (-5.8%)
SMA 20019.81 (-21.5%)
Beta0.22
S&P 52W Chg18.16%
Avg Vol (30d)50.10K
Avg Vol (10d)33.60K
Technical Indicators
RSI (14)34.2
MACD-0.1565
MACD Signal-0.0498
MACD Hist.-0.1066
BB Upper17.26 NOK
BB Middle16.41 NOK
BB Lower15.57 NOK
BB Width10.29%
ATR (14)0.5710 NOK
Vol Ratio (20d)0.44x